Skip to content

Improving Processes of Cancer Care Delivery at a Comprehensive Cancer Center

Mapping the Processes of Cancer Care Delivery at a Comprehensive Cancer Center

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05095948
Enrollment
200
Registered
2021-10-27
Start date
2027-01-30
Completion date
2027-02-02
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Malignant Solid Neoplasm

Brief summary

This study examines how cancer care is delivered in oncology and supportive care clinics. Collecting patient feedback may help doctors better understand the processes of cancer care in oncology and supportive care clinics.

Detailed description

PRIMARY OBJECTIVES: I. To compare the total amount of follow-up clinic time spent on discussing supportive/palliative care issues between primary palliative care provided by the oncology team and specialist palliative care. SECONDARY OBJECTIVES: I. To compare between the specialist palliative care team and the oncology team the following aspects of supportive/palliative care delivery: Ia. The number of supportive/palliative care needs the patient reported before the clinic visit (SPARC). Ib. The number of supportive/palliative care needs the patient wanted to discuss with the clinical team before the clinic visit (SPARC). Ic. The number of supportive/palliative care needs that were actually raised by the patient during the clinic visit (audiotape). Id. The number of supportive/palliative care needs that were actually discussed by the clinical team during clinic visit (audiotape). Ie. The number of supportive/palliative care needs that were documented in progress note by the clinical team after each visit (electronic health record). If. The number of supportive/palliative care needs that the patient reported had been adequate addressed after the clinic visit (SPARC). II. To compare the amount of clinic time (both absolute and proportion) spent on discussing supportive/palliative care issues by individual disciplines (e.g. medical doctor, registered nurse, counselor, pharmacist, psychologist, social worker, and priest) between the specialist palliative care team and the oncology team. III. To examine the nature of topics discussed by the specialist palliative care team and the oncology team and compare the amount of clinic time (both absolute and proportion) spent on each supportive/palliative care issue. IV. To compare the number of empathic statements between the specialist palliative care team and the oncology team. V. To compare the processes of supportive/palliative care delivery between patients seeing the oncology team without specialist palliative care (Cohort A) and patients seeing the oncology team when specialist palliative care team is involved (Cohort B). OUTLINE: Patients complete questionnaires over 15-20 minutes and undergo audio recording of clinic conversations between the oncology team or the specialist palliative care team. Patients' medical records are also reviewed.

Interventions

PROCEDUREDiscussion

Undergo audio recording of clinic conversations

OTHERElectronic Health Record Review

Review of medical records

OTHERQuestionnaire Administration

Complete questionnaires

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Within 6 months of diagnosis of metastatic (or stage IV) solid malignancies * Age 18 or greater * English speaking * Follow-up clinic visit (Supportive Care and Medical Oncology Outpatient Clinics at MD Anderson Cancer Center) * Medical oncologist listed as the attending physician * COHORT A (Oncology team only cohort): Patients should not have been referred to palliative care services at MD Anderson Cancer Center * COHORT B (Oncology team and specialist palliative care cohort): Patients should have an upcoming specialist palliative care follow-up visit within 1 week of a medical oncology visit

Exclusion criteria

* Delirium (Memorial Delirium Assessment Scale \[MDAS\] \>= 13/30) * Significant hearing impairment requiring multiple repetitions during the screening process (that may prolong clinic time)

Design outcomes

Primary

MeasureTime frameDescription
Minutes spent in discussionthrough study completion, an average of 1 yearWill be examined using linear mixed models (LMMs) with physician as the unit of analysis.

Countries

United States

Contacts

CONTACTDavid Hui, MD
dhui@mdanderson.org(713) 792-6258
PRINCIPAL_INVESTIGATORDavid Hui

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026